Biological E slashes Corbevax price in private market to Rs 250 per dose

HYDERABAD:Biological E Limited (BE) on Monday said it is reducing the price of its Covid-19 vaccine Corbevax to Rs 250 per dose (inclusive of GST but excluding administration charges) from Rs 840 per dose (inclusive of GST) for private vaccination centres.
With this, the price of the RBD protein subunit vaccine for the end user along with vaccine administration charges would add up to Rs 400 per dose.
Prior to this price reduction, Corbevax was priced at Rs 990 a dose, including taxes and vaccine administration charges.
The company said the price cut is aimed at making the vaccine more affordable so that it can reach more children and help protect them against the virus.
The decision comes within three weeks of Biological E Limited receiving Emergency Use Authorization (EUA) for Corbevax use in children between 5 and 12 years of age.
The company said Corbevax has also been made available in a single-dose vial, which makes it more convenient for vaccine administration and eliminates vaccine wastage, which is a major advantage for private hospitals.
So far, the company has supplied 100 million doses of Corbevax to the Indian government and over 44 million doses of the vaccine have already been administered to children in the 12-14 years age bracket across the country.